Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases.

Novosadova E, Navratilova Z, Ordeltova M, Zurkova M, Zatloukal J, Kolek V, Petrek M.

J Thorac Dis. 2019 Jun;11(6):2287-2296. doi: 10.21037/jtd.2019.06.05.

2.

Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Kishore A, Navratilova Z, Kolek V, Novosadova E, Čépe K, du Bois RM, Petrek M.

Respirology. 2018 Dec;23(12):1166-1172. doi: 10.1111/resp.13364. Epub 2018 Jun 29.

PMID:
29956871
3.

miR-29a-3p/T-bet Regulatory Circuit Is Altered in T Cells of Patients With Hashimoto's Thyroiditis.

Tokić S, Štefanić M, Glavaš-Obrovac L, Kishore A, Navratilova Z, Petrek M.

Front Endocrinol (Lausanne). 2018 May 24;9:264. doi: 10.3389/fendo.2018.00264. eCollection 2018.

4.

The Serum Expression of Selected miRNAs in Pulmonary Sarcoidosis with/without Löfgren's Syndrome.

Novosadova E, Chabronova A, Kolek V, Petrek M, Navratilova Z.

Mediators Inflamm. 2016;2016:1246129. doi: 10.1155/2016/1246129. Epub 2016 Dec 5.

5.

Expression Profile of Six RNA-Binding Proteins in Pulmonary Sarcoidosis.

Navratilova Z, Novosadova E, Hagemann-Jensen M, Kullberg S, Kolek V, Grunewald J, Petrek M.

PLoS One. 2016 Aug 30;11(8):e0161669. doi: 10.1371/journal.pone.0161669. eCollection 2016.

6.

The Expression of T Cell FOXP3 and T-Bet Is Upregulated in Severe but Not Euthyroid Hashimoto's Thyroiditis.

Tokić S, Štefanić M, Glavaš-Obrovac L, Jaman S, Novosadová E, Petrkova J, Navratilova Z, Suver Stević M, Petrek M.

Mediators Inflamm. 2016;2016:3687420. doi: 10.1155/2016/3687420. Epub 2016 Jul 5.

7.

High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences.

Rivera NV, Ronninger M, Shchetynsky K, Franke A, Nöthen MM, Müller-Quernheim J, Schreiber S, Adrianto I, Karakaya B, van Moorsel CH, Navratilova Z, Kolek V, Rybicki BA, Iannuzzi MC, Petrek M, Grutters JC, Montgomery C, Fischer A, Eklund A, Padyukov L, Grunewald J.

Am J Respir Crit Care Med. 2016 May 1;193(9):1008-22. doi: 10.1164/rccm.201507-1372OC.

8.

Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.

Navratilova Z, Kolek V, Petrek M.

Arch Immunol Ther Exp (Warsz). 2016 Jun;64(3):177-93. doi: 10.1007/s00005-015-0375-5. Epub 2015 Nov 26. Review.

PMID:
26611761
9.

Differential regulation of proinflammatory mediators following LPS- and ATP-induced activation of monocytes from patients with antiphospholipid syndrome.

Martirosyan A, Petrek M, Navratilova Z, Blbulyan A, Boyajyan A, Manukyan G.

Biomed Res Int. 2015;2015:292851. doi: 10.1155/2015/292851. Epub 2015 Feb 15.

10.

Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population.

Navratilova Z, Gallo J, Smizansky M, Mrazek F, Petrek M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Jun;158(2):273-6. doi: 10.5507/bp.2012.024. Epub 2012 Apr 18.

11.

Genetic variation in key molecules of the Th-17 immune response is not associated with risk for prosthetic joint infection in a Czech population.

Navratilova Z, Gallo J, Mrazek F, Petrek M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):248-52. doi: 10.5507/bp.2012.023. Epub 2012 Apr 19.

12.

Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.

Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M.

Respirology. 2012 Aug;17(6):1006-12. doi: 10.1111/j.1440-1843.2012.02197.x.

PMID:
22591289
13.

CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarction.

Tereshchenko IP, Petrkova J, Voevoda MI, Taborsky M, Navratilova Z, Romaschenko AG, Maksimov VN, Mrazek F, Petrek M.

Mediators Inflamm. 2011;2011:525691. doi: 10.1155/2011/525691. Epub 2011 Mar 29.

14.

PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells.

Kriegova E, Arakelyan A, Fillerova R, Zatloukal J, Mrazek F, Navratilova Z, Kolek V, du Bois RM, Petrek M.

BMC Mol Biol. 2008 Jul 31;9:69. doi: 10.1186/1471-2199-9-69.

15.

MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis.

Navratilova Z, Lukac J, Mrazek F, Kriegova E, Bucova M, Bosak V, Petrek M.

Mediators Inflamm. 2008;2008:204063. doi: 10.1155/2008/204063.

16.

The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Löfgren's syndrome.

Navratilova Z, Mrazek F, Kriegova E, Hutyrova B, Kolek V, du Bois RM, Petrek M.

Sarcoidosis Vasc Diffuse Lung Dis. 2007 Mar;24(1):33-8.

PMID:
18069417
17.

Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases.

Navratilova Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006 Nov;150(2):191-204. Review.

Supplemental Content

Loading ...
Support Center